Welcome!

News Feed Item

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312346/Traumatic-Spinal-Cord-Injury-Global-Clinical-Trials-Review-H2-2014.html

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014" provides data on the Traumatic Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Traumatic Spinal Cord Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Traumatic Spinal Cord Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6

Traumatic Spinal Cord Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Traumatic Spinal Cord Injury 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Traumatic Spinal Cord Injury Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Stem Cell Sciences UK Ltd 28

Clinical Trial Overview of Stem Cell Sciences UK Ltd 28
NuVasive, Inc. 29
Clinical Trial Overview of NuVasive, Inc. 29
AOSpine International 30
Clinical Trial Overview of AOSpine International 30
Acorda Therapeutics, Inc. 31
Clinical Trial Overview of Acorda Therapeutics, Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
Simon Fraser University 32
Clinical Trial Overview of Simon Fraser University 32
Tehran University of Medical Sciences 33
Clinical Trial Overview of Tehran University of Medical Sciences 33
Shanghai Changzheng Hospital 34
Clinical Trial Overview of Shanghai Changzheng Hospital 34
Christian Medical College 35
Clinical Trial Overview of Christian Medical College 35
Indian Council of Medical Research 36
Clinical Trial Overview of Indian Council of Medical Research 36
Rennes University Hospital 37
Clinical Trial Overview of Rennes University Hospital 37
Yonsei University 38
Clinical Trial Overview of Yonsei University 38
Capital District Health Authority, Canada 39
Clinical Trial Overview of Capital District Health Authority, Canada 39
Hadassah Medical Organization 40
Clinical Trial Overview of Hadassah Medical Organization 40
University of Miami 41
Clinical Trial Overview of University of Miami 41
Five Key Clinical Profiles 42
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region, 2014* 7
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Traumatic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Traumatic Spinal Cord Injury Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Traumatic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26

Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Stem Cell Sciences UK Ltd, 2014* 28
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by NuVasive, Inc., 2014* 29
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AOSpine International, 2014* 30
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014* 31
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Simon Fraser University, 2014* 32
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 33
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Changzheng Hospital, 2014* 34
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Christian Medical College, 2014* 35
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2014* 36
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Rennes University Hospital, 2014* 37
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 38
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2014* 39
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 40
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 41

List of Figures
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Traumatic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Traumatic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 57

Read the full report:
Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312346/Traumatic-Spinal-Cord-Injury-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that N3N will exhibit at SYS-CON's @ThingsExpo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. N3N’s solutions increase the effectiveness of operations and control centers, increase the value of IoT investments, and facilitate real-time operational decision making. N3N enables operations teams with a four dimensional digital “big board” that consolidates real-time live video feeds alongside IoT sensor data a...
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devic...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...
SYS-CON Events announced today that SourceForge has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. SourceForge is the largest, most trusted destination for Open Source Software development, collaboration, discovery and download on the web serving over 32 million viewers, 150 million downloads and over 460,000 active development projects each and every month.
Today most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes significant work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reducti...
Today traditional IT approaches leverage well-architected compute/networking domains to control what applications can access what data, and how. DevOps includes rapid application development/deployment leveraging concepts like containerization, third-party sourced applications and databases. Such applications need access to production data for its test and iteration cycles. Data Security? That sounds like a roadblock to DevOps vs. protecting the crown jewels to those in IT.
SYS-CON Events announced today that Interface Corporation will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Interface Corporation is a company developing, manufacturing and marketing high quality and wide variety of industrial computers and interface modules such as PCIs and PCI express. For more information, visit http://www.i...
SYS-CON Events announced today that mruby Forum will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. mruby is the lightweight implementation of the Ruby language. We introduce mruby and the mruby IoT framework that enhances development productivity. For more information, visit http://forum.mruby.org/.
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
In his session at @ThingsExpo, Greg Gorman is the Director, IoT Developer Ecosystem, Watson IoT, will provide a short tutorial on Node-RED, a Node.js-based programming tool for wiring together hardware devices, APIs and online services in new and interesting ways. It provides a browser-based editor that makes it easy to wire together flows using a wide range of nodes in the palette that can be deployed to its runtime in a single-click. There is a large library of contributed nodes that help so...
What is the best strategy for selecting the right offshore company for your business? In his session at 21st Cloud Expo, Alan Winters, U.S. Head of Business Development at MobiDev, will discuss the things to look for - positive and negative - in evaluating your options. He will also discuss how to maximize productivity with your offshore developers. Before you start your search, clearly understand your business needs and how that impacts software choices.
IBM helps FinTechs and financial services companies build and monetize cognitive-enabled financial services apps quickly and at scale. Hosted on IBM Bluemix, IBM’s platform builds in customer insights, regulatory compliance analytics and security to help reduce development time and testing. In his session at 21st Cloud Expo, Lennart Frantzell, a Developer Advocate with IBM, will discuss how these tools simplify the time-consuming tasks of selection, mapping and data integration, allowing devel...
SYS-CON Events announced today that Cedexis will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Cedexis is the leader in data-driven enterprise global traffic management. Whether optimizing traffic through datacenters, clouds, CDNs, or any combination, Cedexis solutions drive quality and cost-effectiveness.
SYS-CON Events announced today that Mobile Create USA will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Mobile Create USA Inc. is an MVNO-based business model that uses portable communication devices and cellular-based infrastructure in the development, sales, operation and mobile communications systems incorporating GPS capabi...
While some developers care passionately about how data centers and clouds are architected, for most, it is only the end result that matters. To the majority of companies, technology exists to solve a business problem, and only delivers value when it is solving that problem. 2017 brings the mainstream adoption of containers for production workloads. In his session at 21st Cloud Expo, Ben McCormack, VP of Operations at Evernote, will discuss how data centers of the future will be managed, how th...